Tapentadol Tablet, Film Coated
Product Images NDC 0054-0945

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tapentadol (NDC 0054-0945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tapentadol 01)

Chemical Structure (Tapentadol 01)
Chemical structure of Tapentadol Hydrochloride, showing the molecular arrangement with an aromatic ring, hydroxyl group, and hydrochloride component.*
FDA Label Image

Figure 1 (Tapentadol 02)

Figure 1 (Tapentadol 02)
A Kaplan-Meier plot showing the percent of patients improved over time, comparing placebo and Tapentadol oral tablets at 50 mg, 75 mg, and 100 mg doses. The x-axis represents percent improvement in pain from baseline at hour 48, while the y-axis shows the percent of patients improved. Different line styles distinguish each treatment group.*
FDA Label Image

Figure 2 (Tapentadol 03)

Figure 2 (Tapentadol 03)
A line graph comparing the percent of patients improved with placebo, Tapentadol 50 mg, and Tapentadol 75 mg. The x-axis shows percent improvement in pain from baseline at Day 5 (0 to 100), and the y-axis shows percent of patients improved. The graph illustrates higher improvement percentages for Tapentadol 50 mg and 75 mg versus placebo.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
Tapentadol 50 mg tablets film-coated oral prescription drug label by Hikma Pharmaceuticals USA Inc. The label indicates each tablet contains 50 mg tapentadol. The package contains 100 tablets and includes storage instructions and cautions, including federal law prohibiting transfer and medication guide dispensing.*
FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Label)

Principal Display Panel (75 mg Tablet Bottle Label)
The packaging label is for Tapentadol Tablets with a strength of 75 mg. The label indicates a quantity of 100 tablets, film-coated, for oral use. It is labeled as Rx only, manufactured by Hikma Pharmaceuticals USA Inc. The label includes regulatory information, storage conditions, a barcode, and instructions to dispense the Medication Guide to each patient.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Tapentadol 100 mg film-coated tablets label from Hikma Pharmaceuticals USA Inc. The label states the product name, strength, and quantity of 100 tablets. It includes warnings about prescription use, federal law restrictions, and storage instructions. The NDC number 0054-0945-25 and barcode are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.